SALIX PHARMACEUTCLS (NASDAQ:SLXP)
23.41
0.18 (0.76%)
| SALIX PHARMACEUTCLS (NASDAQ:SLXP) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $23.59 | 52 Week High | $24.23 | ||
| Open | $23.45 | 52 Week Low | $6.14 | ||
| Day High | $23.57 | P/E | N/A | ||
| Day Low | $22.90 | EPS | $-0.94 | ||
| Volume | 1,043,278 | ||||
| More SLXP Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| ALXA | 3 | HDY | 2 |
| KERX | 2 | ELN | 1 |
| DT | 1 | AWK | 1 |
| DGW | 1 | HOLX | 1 |
| NEXM | 1 | SGK | 1 |
| URRE | 1 | MCRI | 1 |
Entities who have mentioned SLXP
- Tracinda Corp. | View Related Stories »
- Kirk Kerkorian | View Related Stories »
- Piper Jaffray | View Related Stories »
- SAC Capital | View Related Stories »
- Steven A. Cohen | View Related Stories »
- 13G | View Related Stories »
- Credit Suisse | View Related Stories »
- Matrix USA | View Related Stories »
- Jefferies & Co | View Related Stories »
- JMP Securities | View Related Stories »
- Daniel Loeb | View Related Stories »
- Banc of America | View Related Stories »
- Roth Capital | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Merriman Curhan Ford | View Related Stories »
- Hedge Funds | View Related Stories »
- UBS | View Related Stories »
- HSBC | View Related Stories »
- Trading Radar | View Related Stories »
- Greenlight Capital | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- JPMorgan | View Related Stories »
- Collins Stewart | View Related Stories »
- Citi | View Related Stories »
- Merrill Lynch | View Related Stories »
View All Major News StreetInsider.com Major News for SLXP
- Salix Pharmaceuticals (SLXP) Reports Mixed Q2 Results
- Salix Pharma (SLXP) Reports Mixed Q1 Earnings; Guides Q2
- Salix Pharma (SLXP) Reports Q4 Loss of $0.22; Guides Q1
View All ReportsStreetInsider.com Reports on SLXP
- Salix (SLXP) December volatility at 56, January at 68, April at 73 into PDUFA
- Salix Pharma (SLXP) Prices 5.5M Share Offering
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Salix Pharma (SLXP) Announces the Issuance of Two Patents Related to Rifaximin
- Salix Pharma (SLXP) Announce Two Rifaximin Studies for Hepatic Encephalopathy Remission Maintenance
View All Press ReleasesCompany Press Releases on SLXP
- Salix Pharmaceuticals, Ltd. Announces Pricing of a Public Offering of Common Stock
- Salix Pharmaceuticals Reports 3Q2009 Results
- Salix Pharmaceuticals to Host Analyst Day on November 18
- Salix Pharmaceuticals to Present at Credit Suisse Conference
- Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin
StreetInsider Reports on SLXP by Category
View All BlogsBlogs on SLXP
- FDA Calendar Extreme Trades: 85 Single Digit Stocks
- Salix: Approval of Rifaximin Would Help Drive Long-Term Growth
- Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
- Closing Update: Stocks Manage Narrowly Higher Finish
- Closing Bell: The China trade war day that didn't come (SLXP, ETFC, UNG, DNDN, GE, MOS)
View All FilingsSEC Filings on SLXP
- Form 4 SALIX PHARMACEUTICALS For: Nov 18 Filed by: DERBYSHIRE ADAM C
- Form 8-K SALIX PHARMACEUTICALS For: Nov 18
- Form 4 SALIX PHARMACEUTICALS For: Nov 11 Filed by: DERBYSHIRE ADAM C
- Form 8-K SALIX PHARMACEUTICALS For: Nov 09
- Form 10-Q SALIX PHARMACEUTICALS For: Sep 30
Comments on SLXP
No comments are currently available.
